The protein levels of hepatic adiponectin and FXR, which are in charge of NASH-related inflammation, fibrosis, and glucose and lipid metabolism disorders, were significantly suppressed in WD-induced mice, while receiving AO extract led to a dose-dependent enhancement (Figure 5b,e). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.